15-min delayed · Sep 4, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Exponent Inc, 2 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $72.00 to $90.00, so the covering firms are broadly aligned. The average target of $81.00 sits 19% above the current $68.35. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.56 next quarter toward $2.84 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy267%
Hold133%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Exponent Inc.
As of Sep, 2 of 3 firms rate EXPO a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
EXPO EPS & revenue forecast
EPS · NEXT QUARTER
$0.56
Range $0.51 – $0.60 · 4 analysts · +14% YoY
Next period, 4 analysts expect Exponent Inc to earn $0.56 a share (range $0.51 – $0.60), versus $0.49 a year earlier. Full-year consensus is $2.51, growing to $2.84 the year after.
REVENUE · NEXT QUARTER
$143.4M
Range $137.7M – $159.0M · 4 analysts · +11% YoY
Revenue is expected to reach $143.4M (range $137.7M – $159.0M), +10.9% year-over-year. Full-year consensus is $606.1M, rising to $658.0M next year.
Top analysts covering Exponent Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EXPO.
#1
TS
Tomohiko Sano
JP Morgan
Buy
$90.00+31.7% to target
Coverage
—
+ Follow
#2
JC
Joshua Chan
UBS
Hold
$72.00+5.3% to target
Coverage
—
+ Follow
#3
Andrew Nicholas
William Blair
Buy
No targeton EXPO
Coverage
—
+ Follow
EXPO stock forecast FAQ
What is EXPO's average 12-month price target?+
The 2 analysts with a live target average $81.00 for Exponent Inc over the next 12 months, ranging from a $90.00 high to a $72.00 low.
Is EXPO stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 2 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for EXPO?+
The Street-high target is $90.00 (JP Morgan), and the Street-low is $72.00 (UBS). The average of all 2 active targets is $81.00.
How many Wall Street analysts cover EXPO?+
3 analysts have an active rating on Exponent Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering EXPO?+
Among analysts who currently cover EXPO, Tomohiko Sano of JP Morgan has the strongest overall Quantellect track record. Their current call is Buy with a $90.00 target.
What is Exponent Inc's projected EPS for next quarter?+
The consensus estimate is $0.56 per share (range $0.51 – $0.60) across 4 analysts. Full-year EPS is projected at $2.51, rising to $2.84 the following year.
How much revenue is Exponent Inc expected to report next quarter?+
Consensus revenue is $143.4M (range $137.7M – $159.0M). Full-year revenue is projected at $606.1M, growing to $658.0M next year.
Have analysts been upgrading or downgrading EXPO lately?+
As of Sep, 2 of 3 firms rate EXPO a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EXPO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
